Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin + rifampin vs colistin + meropenem for Acinetobacter ventilator-associated pneumonia
IRCT20150721023282N22Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in ventilator-associated pneumonia (VAP) and pneumonia comparing Colistin + rifampin with Colistin + meropenem (2 arms). Started Aug 2022; status: completed.
02
Drugs
colistinrifampicinmeropenem
03
Conditions
ventilator-associated pneumonia (VAP)pneumonia
Beyond the preview
Go deeper on IRCT20150721023282N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150721023282N22.